Weston Daniel

Director Program Management at Exicure Operating Co.

Weston Daniel

Weston Daniel

Director Program Management at Exicure Operating Co.

Biography

Weston Daniel is the Director of Program Management at Exicure Inc, where he is responsible for clinical development for the company. Wes received his PhD from Northwestern University in 2010. Wes has 16 published manuscripts, nine issued patents and approximately 30 patent applications. Wes's research has been highlighted in technical and mainstream media outlets, including the New York Times and US News and World Report.

Overview
RelSci Relationships

36

Relationships
RelSci Relationships are individuals Weston Daniel likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Exicure Operating Co.

Relationship likelihood: Strong

Chief Executive Officer at Exicure Operating Co.

Relationship likelihood: Strong

Co-Founder at Quanterix Corp.

Relationship likelihood: Strong

Professional at Assembly Biosciences, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Angion Biomedica Corp.

Relationship likelihood: Strong

Chief Financial Officer at Exicure Operating Co.

Relationship likelihood: Strong

Vice President, Head of Business Development at Exicure Operating Co.

Relationship likelihood: Strong

Chief Operating Officer at Exicure Operating Co.

Relationship likelihood: Strong

Former Chief Scientific Officer at Exicure Operating Co.

Relationship likelihood: Strong

Professional at Exicure Operating Co.

Relationship likelihood: Strong

Paths to Weston Daniel
Potential Connections via
Relationship Science
You
Weston Daniel
Director Program Management at Exicure Operating Co.
Career History
Director Program Management
Current

Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.

Other Affiliations

Weston Daniel is affiliated with Exicure Operating Co.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Weston Daniel. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Weston Daniel's profile does not indicate a business or promotional relationship of any kind between RelSci and Weston Daniel.